F5CTF3 (F5CTF3_HUMAN) Homo sapiens (Human)

Deoxynucleoside kinase UniProtKBInterProInteractive Modelling

260 aa; Sequence (Fasta) ; 1 identical sequence: Homo sapiens: P27707

Available Structures

58 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
S74E-R104M-D133A dCK variant in complex with L-deoxythymidine and UDP
3qeo
 Heteromer
P27707; 		19-260
2×UDP; 2×LLT;
Assess
Human dCK C4S-S74E mutant in complex with UDP and the F2.4.1 inhibitor (2-[({2-[3-(2-FLUOROETHOXY)-…
4jln
homo-2-mer18-260
2×18V; 2×UDP;
Assess
Crystal structure of dCK C4S-S74E mutant in complex with UDP and the OR0634 inhibitor
7zia
homo-2-mer19-260
2×UDP; 2×J29; 2×NA;
Assess
C4S dCK variant of dCK in complex with L-dC+ADP
2no7
homo-2-mer19-260
2×ADP; 2×LDC;
Assess
Crystal structure of dCK C4S-S74E mutant in complex with UDP and the OR0624 inhibitor
7zi9
homo-2-mer19-260
2×UDP; 2×J6M; 2×NA;
Assess
C4S dCK variant of dCK in complex with gemcitabine+ADP
2no0
homo-2-mer19-260
2×ADP; 2×GEO;
Assess
Crystal structure of dCK C4S-S74E mutant in complex with UDP and the OR0345 inhibitor
7zi7
homo-2-mer19-260
2×UDP; 2×JCM; 2×NA;
Assess
The structure of deoxycytidine kinase complexed with lamivudine and ADP.
2noa
homo-2-mer19-260
2×ADP; 2×3TC;
Assess
Human dCK C4S-S74E mutant in complex with UDP and the F2.2.1 inhibitoR (2-[({2-[3-(2-FLUOROETHOXY)-…
4jlk
homo-2-mer19-260
2×UDP; 4×1NO;
Assess
C4S dCK variant of dCK in complex with FTC+ADP
2no6
homo-2-mer19-260
2×ADP; 2×ETV;
Assess
Crystal structure of dCK C4S-S74E mutant in complex with UDP and the OR0642 inhibitor
7zi3
homo-2-mer19-260
2×J98; 2×UDP; 2×NA;
Assess
C4S dCK variant of dCK in complex with D-dC+ADP
2no1
homo-2-mer19-260
2×ADP; 2×DCZ;
Assess
Structure of human dCK complexed with 2'-Deoxycytidine and ADP, Space group C 2 2 21
1p60
homo-2-mer19-260
2×ADP; 2×DCZ;
Assess
Human dCK complex with 5-Me dC and ADP
3kfx
homo-2-mer19-260
2×ADP; 2×MCY;
Assess
Crystal structure of dCK C4S-S74E mutant in complex with UDP and the OR0602 inhibitor
7zi8
homo-2-mer19-260
2×UDP; 2×J5U; 2×NA;
Assess
S74E dCK in complex with 5-bromodeoxycytidine and UDP
3qen
homo-2-mer19-260
2×UDP; 2×5BT;
Assess
Human dCK C4S-S74E mutant in complex with UDP and the inhibitor 4 [1-[5-(4-{[(2,6-diaminopyrimidin-…
4q18
homo-2-mer19-260
4×2XJ; 2×UDP;
Assess
Human dCK C4S-S74E mutant in complex with UDP and the F2.1.1 inhibitor (2-[({2-[3-(2-FLUOROETHOXY)-…
4jlj
homo-2-mer19-260
4×1NM; 2×UDP;
Assess
Crystal structure of dCK C4S-S74E mutant in complex with UDP and the OR0274 inhibitor
7zi5
homo-2-mer19-260
2×UDP; 2×J9I; 2×NA;
Assess
Crystal structure of dCK C4S-S74E mutant in complex with EdC and UDP
8ooj
homo-2-mer19-260
2×UDP; 2×VVC;
Assess
Crystal structure of dCK C4S-S74E mutant in complex with UDP and the OR0325 inhibitor
7zi6
homo-2-mer19-260
2×UDP; 2×JAQ; 2×NA;
Assess
The structure of deoxycytidine kinase complexed with troxacitabine and ADP.
2no9
homo-2-mer19-260
2×ADP; 2×LTT;
Assess
Human dCK C4S-S74E mutant in complex with UDP and the F2.3.1 inhibitor (2-[({5-ETHYL-2-[3-(2-FLUORO…
4jlm
homo-2-mer19-260
3×1NN; 2×UDP;
Assess
Crystal structure of dCK C4S-S74E mutant in complex with UDP and the dCKi2 inhibitor
7zi2
homo-2-mer19-260
2×UDP; 2×J7W; 2×NA;
Assess
S74E-dCK mutant in complex with UDP
3qej
homo-2-mer19-260
2×UDP;
Assess
C4S-E247A dCK variant of dCK in complex with cladribine+ADP
2zi9
homo-2-mer19-260
2×ADP; 2×CL9;
Assess
Crystal structure of dCK mutant C3S in complex with masitinib and UDP
5mql
homo-2-mer19-260
2×UDP; 1×G65; 1×DCM;
Assess
Structure of human dCK complexed with cytarabine and ADP-MG
1p5z
homo-2-mer20-260
2×MG; 2×AR3; 2×ADP;
Assess
C4S dCK variant of dCK in complex with L-dA+UDP
2zi5
homo-2-mer20-260
2×UDP; 2×3L1;
Assess
C4S dCK variant of dCK in complex with D-dA+UDP
2zi6
homo-2-mer20-260
4×UDP; 2×3D1;
Assess
C4S dCK variant of dCK in complex with cladribine+UDP
2zia
homo-2-mer20-260
2×UDP; 2×CL9;
Assess
Human dCK C4S-S74E mutant in complex with UDP and the inhibitor 10 {2-{[(1R/S)-1-{2-[3-(2-fluoroeth…
4q1e
homo-2-mer20-260
2×2Y8; 2×2Y7; 2×UDP;
Assess
Crystal structure of dCK C4S-S74E mutant in complex with UDP and the dCKi1 inhibitor
7zi1
homo-2-mer20-260
2×UDP; 4×JCA; 2×NA;
Assess
Human dCK C4S-S74E mutant in complex with UDP and the inhibitor 6 {2-[5-(4-{[(4,6-diaminopyrimidin-…
4q1a
homo-2-mer20-260
2×2XZ; 2×UDP;
Assess
Structure of human dCK complexed with gemcitabine and ADP-MG
1p62
homo-2-mer20-260
2×MG; 2×ADP; 2×GEO;
Assess
Human dCK C4S-S74E mutant in complex with UDP and the DI-43 inhibitor
4l5b
homo-2-mer20-260
2×1UX; 2×UDP;
Assess
Crystal structure of dCK C4S-S74E mutant in complex with UDP and the OR0635 inhibitor
7zib
homo-2-mer20-260
2×UDP; 2×J7I; 2×NA;
Assess
Human dCK C4S-S74E mutant in complex with UDP and the inhibitor 8 {2,2'-[{4-[(2R)-4-{[(4,6-diaminop…
4q1c
homo-2-mer20-260
2×2XM; 2×UDP;
Assess
Human dCK C4S-S74E mutant in complex with UDP and the inhibitor 9 {2-{[(1R)-1-{2-[3-(2-fluoroethoxy…
4q1d
homo-2-mer20-260
2×2Y1; 2×UDP;
Assess
Human dCK C4S-S74E mutant in complex with UDP and the inhibitor 5 {5-(4-{[(4,6-DIAMINOPYRIMIDIN-2-Y…
4q19
homo-2-mer20-260
2×2XL; 2×UDP;
Assess
Human dCK C4S-S74E mutant in complex with UDP and the DI-39 inhibitor
4kcg
homo-2-mer20-260
2×1QC; 2×UDP;
Assess
Human dCK complex with Acyclic Nucleoside
3mjr
homo-2-mer20-260
2×AC2; 2×UDP;
Assess
C4S dCK variant of dCK in complex with L-dA+ADP
2zi4
homo-2-mer20-260
2×MG; 2×3L1; 2×ADP;
Assess
Human dCK C4S-S74E mutant in complex with UDP and the inhibitor 12R {N-{2-[5-(4-{(1R)-1-[(4,6-diami…
4q1f
homo-2-mer20-260
2×UDP; 2×2XN;
Assess
Human dCK C4S-S74E mutant in complex with UDP and the inhibitor 7 {N-(2-(3-(4-(((4,6-diaminopyrimid…
4q1b
homo-2-mer20-260
2×2Y0; 2×UDP;
Assess
Structure of human dCK complexed with 2'-Deoxycytidine and ADP, P 43 21 2 space group
1p61
homo-2-mer20-260
2×ADP; 2×DCZ;
Assess
C4S-E247A dCK variant of dCK in complex with D-dA+ADP
2zi3
homo-2-mer20-260
2×ADP; 2×3D1;
Assess
Crystal structure of human dCK R104M/D133A in complex with L-dT and ADP
3hp1
homo-2-mer20-260
2×ADP; 2×LLT;
Assess
Crystal structure of human dCK complexed with clofarabine and ADP
2a7q
homo-2-mer20-260
2×MG; 2×ADP; 2×CFB;
Assess
Crystal Structure of human deoxycytidine kinase in complex with deoxycytidine and uridine diphospha…
2a2z
homo-2-mer20-260
1×CA; 2×MG; 2×DCZ; 2×UDP;
Assess
Crystal structure of human deoxycytidine kinase in complex with deoxycytidine
2a30
homo-2-mer20-260
1×CA; 2×DCZ;
Assess
Crystal structure of dCK mutant C3S in complex with imatinib and UDP
5mqt
homo-2-mer20-260
2×UDP; 1×STI; 1×MG; 1×DCM;
Assess
Human Deoxycytidine kinase dCMP, UDP, Mg ion product complex
2qrn
homo-2-mer20-260
2×MG; 2×UDP; 2×DCM;
Assess
Human Deoxycytidine kinase dAMP, UDP, Mg ion product complex
2qro
homo-2-mer20-260
2×MG; 2×UDP; 2×D5M;
Assess
Crystal structure of dCK mutant C3S
5mqj
homo-2-mer20-260
2×UDP; 2×UMP; 2×MG;
Assess
C4S dCK variant of dCK in complex with D-dG+UDP
2zi7
homo-2-mer21-260
2×GNG; 2×UDP;
Assess
X-Ray structure of Human Deoxycytidine Kinase in complex with ADP and an inhibitor
3ipx
monomer20-260
1×ADP; 1×B86; 1×MG;
Assess
X-Ray structure of Human Deoxycytidine Kinase in complex with an inhibitor
3ipy
monomer20-260
1×MLT; 2×B87;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
2qrn.1.Amonomer0.8220-260
1×MG; 1×UDP; 1×DCM;100.00
Assess